Evaluation of effect on inflammation and oxidative stress of Citrate Dialysis fluid with central delivery system for maintenance hemodialysis patients
- Conditions
- Symptoms, signs and abnormal clinical and laboratory findings, NEC
- Registration Number
- KCT0002273
- Lead Sponsor
- Kyung Hee University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 66
(1) Patients aged 20-80 years
(2) Patients on dialysis with end-stage renal failure
(3) Patients on stable maintence dialysis for 6 months
(4) Outpatient
(5) A person who has signed a written agreement
(1) Those who have allergies to Citrate or had a history of adverse reactions
(2) Those who received significant surgical and medical treatment within 3 months of participating in the study
(3) Patients with liver dysfunction (AST, ALT> 3 times the upper limit of normal)
(4) Current cancer patients with malignant tumors or patients who have not been diagnosed with cure
(5) Prevalence of serious infectious diseases
(6) Pregnant and lactating women
(7) Those participating in the clinical trials currently under research and development
(8) Other patients who were judged to be inadequate by the tester
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method remic toxin;Inflammatory Cytokine; Oxidative mediator
- Secondary Outcome Measures
Name Time Method